Clinical Trials on Human Immunodeficiency Virus (HIV) Prophylaxis
Total 11625 results
-
Auritec PharmaceuticalsEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHuman Immunodeficiency Virus (HIV) ProphylaxisUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingProphylaxis | Human Immunodeficiency Virus Type 1 | HIV-IUnited States, South Africa, Uganda
-
Merck Sharp & Dohme LLCWithdrawnHIV-1 | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1 | Human Immunodeficiency Virus 1
-
National Institute of Allergy and Infectious Diseases...CompletedHuman Immunodeficiency Virus (HIV) | Human Immunodeficiency Virus PreventionUnited States
-
RTI InternationalCenters for Disease Control and PreventionCompletedHuman Immunodeficiency Virus (HIV) PositiveUnited States
-
Bristol-Myers SquibbCompleted
-
Janssen-Cilag International NVCompletedHuman Immunodeficiency Virus (HIV) Infections | Acquired Immunodeficiency Syndrome (AIDS) VirusFrance, United Kingdom, Belgium, Germany, Spain, Switzerland, Denmark, Israel, Austria, Poland, Hungary, Sweden, Ireland
-
Merck Sharp & Dohme LLCRecruitingHuman Immunodeficiency Virus (HIV) InfectionUnited States, Mexico, Russian Federation, South Africa, Thailand
-
Fundación Pública Andaluza Progreso y SaludGilead SciencesCompletedHuman Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected SubjectsSpain
-
Janssen Inc.CompletedHuman Immunodeficiency Virus (HIV)Canada
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID); New York University and other collaboratorsCompletedHIV (Human Immunodeficiency Virus)Swaziland
-
Columbia UniversityMinistry of Health, SwazilandCompleted
-
Bristol-Myers SquibbMedarexCompletedHuman Immunodeficiency Virus (HIV)United States
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedHuman Immunodeficiency Virus (HIV)United States, Puerto Rico
-
Janssen-Cilag S.p.A.CompletedHuman Immunodeficiency Virus; HIV
-
MacroGenicsNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsActive, not recruitingHuman Immunodeficiency Virus I Infection | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1United States
-
AbbVieCompletedHuman Immunodeficiency Virus (HIV)United States, Puerto Rico
-
Merck Sharp & Dohme LLCWithdrawnHuman Immunodeficiency Virus (HIV) Infections
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedHuman Immunodeficiency Virus (HIV)-1 InfectionUnited States, Spain, Germany, Dominican Republic
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedSexually Transmitted Diseases | HIV (Human Immunodeficiency Virus)United States
-
Merck Sharp & Dohme LLCCompleted
-
St Vincent's Hospital, SydneyMerck Sharp & Dohme LLCTerminatedHuman Immunodeficiency Virus (HIV) | HIV Associated Neurocognitive Disorders (HAND)Australia
-
RetroLead (Shanghai) BioPharma Co., Ltd.Not yet recruitingHuman Immunodeficiency Virus-1 (HIV-1) Infection
-
Bristol-Myers SquibbCompletedHuman Immunodeficiency Virus Type 1 (HIV-1)United States
-
Bristol-Myers SquibbCompletedHIV Infections | Human Immunodeficiency Virus Type 1 (HIV-1)United States, Netherlands
-
Bruce BrewViiV HealthcareCompletedHuman Immunodeficiency Virus (HIV) | HIV Associated Neurocognitive Disorders (HAND)Australia
-
Johns Hopkins UniversityNational Institutes of Health (NIH)CompletedHuman Immunodeficiency Virus Positive or NegativeUnited States
-
ViiV HealthcareJanssen Research and DevelopmentCompletedHuman Immunodeficiency Virus Type 1 (HIV-1)Germany, Spain, United States, Italy, Canada, Argentina, Sweden
-
University of PennsylvaniaNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHuman Immunodeficiency Virus (HIV) | Sexually Transmitted Disease (STD)United States
-
Merck Sharp & Dohme LLCCompletedHuman Immunodeficiency Virus-1 (HIV-1)
-
Columbia UniversityCompletedHIV (Human Immunodeficiency Virus)United States
-
Tibotec Pharmaceuticals, IrelandCompletedHIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
-
EMD SeronoCompletedHuman Immunodeficiency Virus Infections | Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
-
GlaxoSmithKlineCompletedHIV Infection | HIV-1 Infection | Infection, Human Immunodeficiency Virus INetherlands, Finland, Ireland, Portugal, Switzerland
-
EMD SeronoCompletedHuman Immunodeficiency Virus Infections | Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
-
University of MiamiCompleted
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsCompletedHuman Immunodeficiency Virus Type 1 (HIV-1)United States, Spain, Canada, United Kingdom, South Africa, Japan
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedSexually Transmitted Disease (STD) | Human Immunodeficiency Virus Infection (HIV)United States
-
Janssen PharmaceuticaWithdrawnHuman Immunodeficiency Virus Type 1 (HIV-1) Infection
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus | Infections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
University of California, BerkeleyNational Institute of Mental Health (NIMH); Ministry of Health, Tanzania; Management... and other collaboratorsActive, not recruiting
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency VirusUnited States, Puerto Rico
-
AbbVieCompletedHIV Infection | HIV-1 | Human Immunodeficiency Virus (HIV)United States, Australia, Canada, Puerto Rico
-
Marie-Josée BrouilletteFonds de la Recherche en Santé du Québec; CIHR Canadian HIV Trials NetworkTerminatedHIV - Human Immunodeficiency Virus | Cognitive SymptomsCanada
-
AbbottCompletedHuman Immunodeficiency Virus InfectionsUnited States, Australia, Belgium, Canada, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland, Taiwan, United Kingdom
-
Janssen R&D IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, Belgium, Spain, Switzerland, Sweden, Canada, Puerto Rico, Poland
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusSpain, France, Germany
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
Janssen-Cilag S.p.A.Completed